Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Henry S. Bienen currently holds 5,757 shares of Onconova Therapeutics, Inc. (ONTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Henry S. Bienen has been a net buyer of ONTX stock. They have purchased $128.8K and sold $0 worth of shares.
Henry S. Bienen's most recent insider trade was on Apr 28, 2026, when they sold 5,757 shares at $0.00 per share.
Henry S. Bienen serves as Executive at Onconova Therapeutics, Inc. (ONTX). They have executed 35 insider transactions totaling $128.8K over their tenure at the company.
Henry S. Bienen holds the position of Executive at Onconova Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Henry S. Bienen has shown a buying trading pattern, with $128.8K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Henry S. Bienen was on Dec 22, 2006, when they sold $202.4K worth of BSC shares. This transaction involved 2,043 shares at $99.07 per share.
Henry S. Bienen currently owns 5,757 shares of Onconova Therapeutics, Inc. (ONTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Henry S. Bienen's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Henry S. Bienen has 35 Form 4 filings on record as an insider at Onconova Therapeutics, Inc..
Set alerts for Henry S. Bienen and 40,000+ other insiders.